Endoprotech Inc.

Louisville, KY

UEI
TGWXNHCYTTR3
CAGE
47R21
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1044 E Chestnut St, Louisville, KY 40204, USA
Website
endoprotech.com
Founded
2005
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A novel lipotherapy to reduce infarct size following myocardial infarction R44HL132649 National Heart Lung and Blood Institute (NIH) $1,485,754
A novel lipotherapy to reduce infarct size following myocardial infarction R43HL132649 National Institutes of Health $224,812
Novel drug carrier system for the treatment of alcoholic liver disease R44AA021331 National Institute on Alcohol Abuse and Alcoholism (NIH) $1,339,220
Device for delivery of rolipram to liver for treatment of alcoholic liver disease R43AA021331 National Institutes of Health $277,707
New anti-complement therapy to reduce reperfusion injury: phase II R42HL079855 National Institutes of Health $963,666

Quick answers

Is Endoprotech Inc. registered in SAM.gov?

Yes. Endoprotech Inc.'s SAM.gov registration is active through July 8, 2027.

What is Endoprotech Inc.'s most recent federal award?

Endoprotech Inc.'s most recent federal grant award is A novel lipotherapy to reduce infarct size following myocardial infarction (R44HL132649), from National Heart Lung and Blood Institute (NIH), on July 1, 2016.

On GovTribe

See Endoprotech Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login